The blood-brain barrier hypothesis in drug resistant epilepsy

Brain

Volumn 135, Issue 4, 2012, Pages

  Marchi, Nicola ^a   Granata, Tiziana ^b   Alexopoulos, Andreas ^a   Janigro, Damir ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CORTICOSTEROID; KETAMINE; MAGNESIUM; MAGNESIUM SULFATE; PROPOFOL; SEVOFLURANE; THIOPENTAL;

ANTICONVULSANT THERAPY; ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; DRUG BRAIN LEVEL; DRUG MECHANISM; EPILEPTIC STATE; HUMAN; IMMUNOMODULATION; INDUCED HYPOTHERMIA; KETOGENIC DIET; LETTER; PRIORITY JOURNAL; SUPER REFRACTORY EPILEPTIC STATE; VAGUS NERVE STIMULATION;

EID: 84860182383     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr343     Document Type: Letter

References (22)

1. Amtorp O, Sorensen SC. The ontogenetic development of concentration differences for protein and ions between plasma and cerebrospinal fluid in rabbits and rats. J Physiol 1974; 243: 387-400.
2. Beghi E, Shorvon S. Antiepileptic drugs and the immune system. Epilepsia 2011; 52: 40-4.
3. Beilin B, Rusabrov Y, Shapira Y, Roytblat L, Greemberg L, Yardeni IZ, et al. Low-dose ketamine affects immune responses in humans during the early postoperative period. Br J Anaesth 2007; 99: 522-7. (Pubitemid 47412495)
4. Cheyuo C, Wu RQ, Zhou MA, Jacob A, Coppa G, Wang P. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 2011; 35: 258-65.
5. Heath DL, Vink R. Neuroprotective effects of MgSO4 and MgCl2 in close head injury: a comparative phosphorus NMR study. J. Neurotrauma 1998; 15: 183-9. (Pubitemid 28113578)
6. Jaaskelainen SK, Kaisti K, Suni L, Hinkka S, Scheinin H. Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia. Neurology 2003; 61: 1073-78. (Pubitemid 37461940)
7. Janigro D. Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Res 1999; 37: 223-32. (Pubitemid 29476520)
8. Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, Betto G, et al. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol. Dis 2009; 33: 171-81.
9. Marchi N, Granata T, Freri E, Ciusani E, Ragona F, Puvenna V, et al. Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One 2011; 6: e18200.
10. Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011; 10: 99-108.
11. Oztas B, Kaya M. The effect of profound hypothermia on blood-brain barrier permeability during pentylenetetrazol-induced seizures. Epilepsy Res 1994; 19: 221-7.
12. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009; 37: S186-S202.
13. Roesslein M, Schibilsky D, Muller L, Goebel U, Schwer C, Humar M, et al. Thiopental protects human T lymphocytes from apoptosis in vitro via the expression of heat shock protein 70. J Pharmacol Exp Ther 2008; 325: 217-25. (Pubitemid 351439174)
14. Rosas-Ballina M, Olofsson PS, Ochani M, Valdes-Ferrer SI, Levine YA, Reardon C, et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011; 334: 98-101.
15. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med 2009; 265: 663-79.
16. Sanchez-Conde P, Rodriguez-Lopez JM, Nicolas JL, Lozano FS, Garcia-Criado FJ, Cascajo C, et al. The comparative abilities of propofol and sevoflurane to modulate inflammation and oxidative stress in the kidney after aortic cross-clamping. Anesth Analg 2008; 106: 371-8, table. (Pubitemid 351156656)
17. Schneemilch CE, Hachenberg T, Ansorge S, Ittenson A, Bank U. Effects of different anaesthetic agents on immune cell function in vitro. Eur J Anaesthesiol 2005; 22: 616-23. (Pubitemid 41097865)
18. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011; 134: 2802-18.
19. Verhelst H, Boon P, Buyse G, Ceulemans B, D'Hooghe M, De Meirleir L, et al. Steroids in intractable childhood epilepsy: clinical experience and review of the literature. Seizure 2005; 14: 412-21. (Pubitemid 41200494)
20. Webster CM, Kelly S, Koike MA, Chock VY, Giffard RG, Yenari MA. Inflammation and NFkappaB activation is decreased by hypothermia following global cerebral ischemia. Neurobiol Dis 2009; 33: 301-12.
21. Welters ID, Feurer MK, Preiss V, Muller M, Scholz S, Kwapisz M, et al. Continuous S-( + )-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth 2011; 106: 172-9.
22. Welters ID, Hafer G, Menzebach A, Muhling J, Neuhauser C, Browning P, et al. Ketamine inhibits transcription factors activator protein 1 and nuclear factor-kappaB, interleukin-8 production, as well as CD11b and CD16 expression: studies in human leukocytes and leukocytic cell lines. Anesth Analg 2010; 110: 934-41.